Pharma News - Chemdiv

AbbVie adds to Vraylar data as FDA considers depression use

AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar in treatment-resistant depression, as it waits for a decision by the FDA on the new indication. ...

Bavarian Nordic Enters First Larger Vaccine Contract with Government in Response to Monkeypox Outbreak

Bavarian Nordic A/S (OMX: BAVA) announced today the signing of a supply contract with an undisclosed country for the Company’s smallpox vaccine with the aim to ensure sufficient supply to meet th...

Pfizer and Lilly Zero in on Success in Ulcerative Colitis

Two big pharma companies are forging ahead with ulcerative colitis (UC) research after posting positive results from their respective Phase III studies.

Junshi Biosciences Oral Covid Drug Wraps Up Trials, to Seek Sales Approval

Drug developer Shanghai Junshi Biosciences Co. Ltd. (1877.HK; 688180.SH) announced late Monday that VV116, an oral drug developed by its JunTop Biosciences unit for the early treatment of Covid-19,...

Europe: Pause recommended for 100 generics

Approval for around 100 generics in Europe is to be suspended because a contract institute in India has worked poorly in the studies relevant to the approval of the drugs.

Pfizer Expected to Pay $290,000 to Patients in Four States in Settlement

Pfizer has agreed to pay $290,000 to patients in Colorado, Vermont, Arizona and Kansas to settle allegations over alleged misleading copay coupons for four drugs. ...

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)

SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, announced that the U.S. Food and Drug Administration (FDA) approved the int...

Trial on Vaccine for Pancreatic Cancer Prevention

US scientists have begun a trial on a vaccine that will shield individuals from developing pancreatic cancer.

Medicinal Cannabis May Compensate Cancer-related Pain

Pain and need for opiate painkillers among cancer patients may be reduced by medicinal cannabis as per a study published in Frontiers in Pain Research.

Bayer bails on $670m CAR-T partnership with Atara

In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a patient death. Now, its partner Bayer has backed out of a partnership covering two ...

CHMP backs Sanofi’s Xenpozyme as first drug for ASMD

Sanofi’s Genzyme unit has moved a step closer to securing EU approval for Xenpozyme – its enzyme replacement therapy for rare disease acid sphingomyelinase deficiency (ASMD) – after scoring ...

AbbVie files continuous Parkinson’s therapy ABBV-951 in US

AbbVie has filed for approval of its therapy for Parkinson’s disease, ABBV-951, which promises continuous control of symptoms and would be an alternative to current drugs that often fail to contr...